This in turn increases OGG1 expression and promotes BER efficiency in HCC. Moreover, data suggested that RBM39 degradation, combined with oxidative damage, could be more effective for HCC treatment than monotherapy, both in vitro and in xenograft mice models.
Countstar Connection
The study's cell samples underwent cell-count assessment with Countstar (model not specified) during quality assessment in the 2025 Cell proliferation study.
